InsiderTrades

Form 4 for NTRA Natera, Inc.

Accepted 2021-09-21 00:00:00 ET · period of report 2021-09-17 · accession 0001415889-21-004514 · SEC index · Original document

Summary rows

Aggregated the way they appear in lists: one row per insider, transaction code and security table.

X Filed Traded Ticker Insider Title Type Price Qty Owned ΔOwn Value
DM 2021-09-21 2021-09-17 NTRA Chapman Rowan E Dir S - Sale+OE $120.78 -5,500 9,356 -37% -$664.3K
D 2021-09-21 2021-09-17 NTRA Chapman Rowan E Dir M - OptEx $32.15 +5,500 10.4K +113% +$176.8K
D 2021-09-21 2021-09-17 NTRA Chapman Rowan E Dir M - OptEx $0.00 -5,500 11.0K -33% $0

Purchase Sale Sale after option exercise All abbreviations

Every reported transaction

#TableSecurityDateCodeA/DSharesPriceOwned afterOwnExercise / expiryUnderlyingFootnotes
1 Common Common Stock 2021-09-17 S D 4,500 $120.93 4,856 D — — (F1) The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on June 14, 2021. The Reporting Person is subject to a Lock-up Letter Agreement that expired on September 19, 2021. The sale of shares is a permissible exemption under the terms of the Lock-Up Letter Agreement. (F3) The reported price in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $120.48 to $121.30 per share, inclusive. The holder undertakes to provide, upon written request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote. (F4) These reported shares are subject to restrictions in the Lock-Up Letter Agreement.
2 Common Common Stock 2021-09-17 S D 1,000 $120.08 9,356 D — — (F1) The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on June 14, 2021. The Reporting Person is subject to a Lock-up Letter Agreement that expired on September 19, 2021. The sale of shares is a permissible exemption under the terms of the Lock-Up Letter Agreement. (F2) The reported price in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $119.46 to $120.38 per share, inclusive. The holder undertakes to provide, upon written request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote.
3 Common Common Stock 2021-09-17 M A 5,500 $32.15 10,356 D — —
4 Derivative Stock Option (right to buy) 2021-09-17 M D 5,500 $0.00 11,000 D $32.15 · — to 2029-09-26 5,500 Common Stock (F5) The option shares vest over three years. A third of the option shares vested and became exercisable on August 15, 2020 and the remaining shares vest in 2 equal annual installments thereafter.